🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Sabra Healthcare stock hits 52-week high at $19.79 amid robust growth

Published 2024-11-11, 12:04 p/m
SBRA
-

In a remarkable display of resilience and growth, Sabra Healthcare REIT Inc (NASDAQ:SBRA)'s stock has soared to a 52-week high, reaching a price level of $19.79 USD. This peak reflects a significant uptrend for the healthcare-focused real estate investment trust, which has seen an impressive 1-year change of 39.75%. Investors have shown increased confidence in the company's portfolio of healthcare properties, including skilled nursing and senior housing facilities, as the sector continues to demonstrate strong demand. The 52-week high milestone underscores the positive sentiment surrounding Sabra Healthcare's operational performance and strategic initiatives, which have been pivotal in driving the company's stock value upward over the past year.

In other recent news, Zebra reported a positive financial performance in its Q3 2024 earnings call. The company highlighted consecutive quarters of improvement, with significant increases in skilled nursing facility occupancy and 7.6% year-over-year revenue growth. A quarterly dividend of $0.30 per share was also declared. The company's updated 2024 guidance projects normalized FFO per share between $1.39 and $1.40, and normalized AFFO between $1.41 and $1.42. Despite a slight dip in senior housing triple net segment occupancy, management expressed confidence in future occupancy growth and a disciplined approach to acquisitions. Notably, Zebra recently acquired a senior housing asset with an initial yield above 8%. These are among the recent developments for Zebra, as reported in the company's earnings call.

InvestingPro Insights

Sabra Healthcare REIT Inc's recent performance aligns well with several key metrics and insights from InvestingPro. The company's stock has indeed shown remarkable strength, with InvestingPro data revealing a 50.15% total return over the past year and a robust 39.99% return in just the last six months. This performance is further emphasized by the stock trading at 99.44% of its 52-week high, confirming the article's observation of reaching new peaks.

InvestingPro Tips highlight that Sabra has maintained dividend payments for 14 consecutive years, which is particularly relevant for income-focused REIT investors. Additionally, the company's profitability over the last twelve months and analysts' expectations of continued profitability this year underscore its financial stability.

For investors seeking a deeper understanding of Sabra's valuation and growth prospects, InvestingPro offers 7 additional tips, providing a more comprehensive analysis of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.